Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering
- Autores
- Fernandez, Juan Manuel; Molinuevo, María Silvina; Cortizo, Maria Susana; McCarthy, Antonio Desmond; Cortizo, Ana María
- Año de publicación
- 2011
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Hydroxyapatite (HAP)-containing poly-å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications.
Fil: Fernandez, Juan Manuel. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas; Argentina
Fil: Molinuevo, María Silvina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina
Fil: Cortizo, Maria Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina
Fil: McCarthy, Antonio Desmond. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina
Fil: Cortizo, Ana María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas; Argentina - Materia
-
BIOCOMPATIBILITY
BONE TISSUE ENGINEERING
HYDROXYAPATITE
OSTEOBLASTS
POLY-Ε-CAPROLACTONE
POLYDIALKYL FUMARATES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/196488
Ver los metadatos del registro completo
id |
CONICETDig_a1a812d70c2c126a279de97ea9bdf992 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/196488 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineeringFernandez, Juan ManuelMolinuevo, María SilvinaCortizo, Maria SusanaMcCarthy, Antonio DesmondCortizo, Ana MaríaBIOCOMPATIBILITYBONE TISSUE ENGINEERINGHYDROXYAPATITEOSTEOBLASTSPOLY-Ε-CAPROLACTONEPOLYDIALKYL FUMARATEShttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Hydroxyapatite (HAP)-containing poly-å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications.Fil: Fernandez, Juan Manuel. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas; ArgentinaFil: Molinuevo, María Silvina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; ArgentinaFil: Cortizo, Maria Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; ArgentinaFil: McCarthy, Antonio Desmond. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; ArgentinaFil: Cortizo, Ana María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas; ArgentinaJohn Wiley & Sons Ltd2011-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/196488Fernandez, Juan Manuel; Molinuevo, María Silvina; Cortizo, Maria Susana; McCarthy, Antonio Desmond; Cortizo, Ana María; Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering; John Wiley & Sons Ltd; Journal Of Tissue Engineering And Regenerative Medicine; 5; 6; 6-2011; 126-1351932-6254CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/term.394info:eu-repo/semantics/altIdentifier/doi/10.1002/term.394info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:08:30Zoai:ri.conicet.gov.ar:11336/196488instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:08:30.422CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
title |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
spellingShingle |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering Fernandez, Juan Manuel BIOCOMPATIBILITY BONE TISSUE ENGINEERING HYDROXYAPATITE OSTEOBLASTS POLY-Ε-CAPROLACTONE POLYDIALKYL FUMARATES |
title_short |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
title_full |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
title_fullStr |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
title_full_unstemmed |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
title_sort |
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering |
dc.creator.none.fl_str_mv |
Fernandez, Juan Manuel Molinuevo, María Silvina Cortizo, Maria Susana McCarthy, Antonio Desmond Cortizo, Ana María |
author |
Fernandez, Juan Manuel |
author_facet |
Fernandez, Juan Manuel Molinuevo, María Silvina Cortizo, Maria Susana McCarthy, Antonio Desmond Cortizo, Ana María |
author_role |
author |
author2 |
Molinuevo, María Silvina Cortizo, Maria Susana McCarthy, Antonio Desmond Cortizo, Ana María |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
BIOCOMPATIBILITY BONE TISSUE ENGINEERING HYDROXYAPATITE OSTEOBLASTS POLY-Ε-CAPROLACTONE POLYDIALKYL FUMARATES |
topic |
BIOCOMPATIBILITY BONE TISSUE ENGINEERING HYDROXYAPATITE OSTEOBLASTS POLY-Ε-CAPROLACTONE POLYDIALKYL FUMARATES |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.4 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Hydroxyapatite (HAP)-containing poly-å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. Fil: Fernandez, Juan Manuel. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas; Argentina Fil: Molinuevo, María Silvina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina Fil: Cortizo, Maria Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina Fil: McCarthy, Antonio Desmond. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina Fil: Cortizo, Ana María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas; Argentina |
description |
Hydroxyapatite (HAP)-containing poly-å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. å-caprolactone (PCL)/ polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-at-break of Blend-HAP suggest that the mechanical properties of the HAP-scaffolds have improved significantly. The addition of HAP to both PCL and Blend, significantly improves the cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several observations: a) HAP-Polymer increases proliferation of osteoblastic cells, b) HAP included in the blend increases the ALP expression in UMR106 cells, c) HAP-Blend increases the type-I collagen production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP-polymer scaffolds. In conclusion, a novel biocompatible HAP-Blend composite with uniform dispersion of semi-nano HAP particles and good inter-phase compatibility has been prepared successfully. The development of HAP-Blend composite, with improved physical, mechanical and osteoinductive properties may be potentially used in bone tissue engineering applications. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/196488 Fernandez, Juan Manuel; Molinuevo, María Silvina; Cortizo, Maria Susana; McCarthy, Antonio Desmond; Cortizo, Ana María; Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering; John Wiley & Sons Ltd; Journal Of Tissue Engineering And Regenerative Medicine; 5; 6; 6-2011; 126-135 1932-6254 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/196488 |
identifier_str_mv |
Fernandez, Juan Manuel; Molinuevo, María Silvina; Cortizo, Maria Susana; McCarthy, Antonio Desmond; Cortizo, Ana María; Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering; John Wiley & Sons Ltd; Journal Of Tissue Engineering And Regenerative Medicine; 5; 6; 6-2011; 126-135 1932-6254 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/term.394 info:eu-repo/semantics/altIdentifier/doi/10.1002/term.394 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
John Wiley & Sons Ltd |
publisher.none.fl_str_mv |
John Wiley & Sons Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270047356059648 |
score |
13.13397 |